Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.48
WAT's Cash to Debt is ranked lower than
54% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. WAT: 1.48 )
Ranked among companies with meaningful Cash to Debt only.
WAT' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 1.1 Max: 336.71
Current: 1.48
0
336.71
Equity to Asset 0.48
WAT's Equity to Asset is ranked lower than
69% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. WAT: 0.48 )
Ranked among companies with meaningful Equity to Asset only.
WAT' s Equity to Asset Range Over the Past 10 Years
Min: 0.11  Med: 0.45 Max: 0.7
Current: 0.48
0.11
0.7
Interest Coverage 14.79
WAT's Interest Coverage is ranked lower than
61% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.93 vs. WAT: 14.79 )
Ranked among companies with meaningful Interest Coverage only.
WAT' s Interest Coverage Range Over the Past 10 Years
Min: 5.71  Med: 16.44 Max: 35.92
Current: 14.79
5.71
35.92
F-Score: 5
Z-Score: 6.66
M-Score: -2.54
WACC vs ROIC
7.27%
39.19%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 27.70
WAT's Operating margin (%) is ranked higher than
94% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.16 vs. WAT: 27.70 )
Ranked among companies with meaningful Operating margin (%) only.
WAT' s Operating margin (%) Range Over the Past 10 Years
Min: 23.05  Med: 26.75 Max: 28.55
Current: 27.7
23.05
28.55
Net-margin (%) 23.33
WAT's Net-margin (%) is ranked higher than
93% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.53 vs. WAT: 23.33 )
Ranked among companies with meaningful Net-margin (%) only.
WAT' s Net-margin (%) Range Over the Past 10 Years
Min: 17.36  Med: 22.34 Max: 25.03
Current: 23.33
17.36
25.03
ROE (%) 23.97
WAT's ROE (%) is ranked higher than
93% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.61 vs. WAT: 23.97 )
Ranked among companies with meaningful ROE (%) only.
WAT' s ROE (%) Range Over the Past 10 Years
Min: 23.6  Med: 38.77 Max: 68.79
Current: 23.97
23.6
68.79
ROA (%) 11.53
WAT's ROA (%) is ranked higher than
87% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. WAT: 11.53 )
Ranked among companies with meaningful ROA (%) only.
WAT' s ROA (%) Range Over the Past 10 Years
Min: 11.52  Med: 15.5 Max: 18.41
Current: 11.53
11.52
18.41
ROC (Joel Greenblatt) (%) 79.68
WAT's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.27 vs. WAT: 79.68 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WAT' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 72.34  Med: 86.76 Max: 99.06
Current: 79.68
72.34
99.06
Revenue Growth (3Y)(%) 5.90
WAT's Revenue Growth (3Y)(%) is ranked higher than
57% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. WAT: 5.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WAT' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.2  Med: 8.9 Max: 17.8
Current: 5.9
5.2
17.8
EBITDA Growth (3Y)(%) 7.00
WAT's EBITDA Growth (3Y)(%) is ranked higher than
51% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.90 vs. WAT: 7.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WAT' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.4  Med: 11 Max: 69.2
Current: 7
2.4
69.2
EPS Growth (3Y)(%) 2.90
WAT's EPS Growth (3Y)(%) is ranked lower than
56% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. WAT: 2.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WAT' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.6  Med: 14.6 Max: 79.9
Current: 2.9
2.6
79.9
» WAT's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-27)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

WAT Guru Trades in Q3 2015

Jim Simons 294,800 sh (+157.05%)
Ray Dalio 8,904 sh (+142.95%)
John Hussman 20,000 sh (unchged)
Ruane Cunniff 2,038,353 sh (-0.59%)
Chuck Royce 14,437 sh (-6.56%)
PRIMECAP Management 657,721 sh (-7.59%)
Paul Tudor Jones 5,300 sh (-8.43%)
Jeremy Grantham 54,090 sh (-57.91%)
Joel Greenblatt 25,527 sh (-71.35%)
» More
Q4 2015

WAT Guru Trades in Q4 2015

Jim Simons 296,696 sh (+0.64%)
Chuck Royce 14,437 sh (unchged)
Joel Greenblatt Sold Out
Ray Dalio Sold Out
PRIMECAP Management 651,117 sh (-1.00%)
Ruane Cunniff 1,995,247 sh (-2.11%)
John Hussman 15,000 sh (-25.00%)
Jeremy Grantham 36,790 sh (-31.98%)
Paul Tudor Jones 3,200 sh (-39.62%)
» More
Q1 2016

WAT Guru Trades in Q1 2016

Joel Greenblatt 24,086 sh (New)
John Hussman Sold Out
Paul Tudor Jones Sold Out
PRIMECAP Management 650,867 sh (-0.04%)
Ruane Cunniff 1,920,738 sh (-3.73%)
Chuck Royce 11,387 sh (-21.13%)
Jim Simons 169,200 sh (-42.97%)
Jeremy Grantham 2,109 sh (-94.27%)
» More
Q2 2016

WAT Guru Trades in Q2 2016

Paul Tudor Jones 2,800 sh (New)
Louis Moore Bacon 18,000 sh (New)
Ray Dalio 2,600 sh (New)
Pioneer Investments 8,690 sh (New)
Joel Greenblatt 105,556 sh (+338.25%)
Jeremy Grantham Sold Out
Jim Simons Sold Out
PRIMECAP Management 628,667 sh (-3.41%)
Ruane Cunniff 1,770,014 sh (-7.85%)
Chuck Royce 5,047 sh (-55.68%)
» More
» Details

Insider Trades

Latest Guru Trades with WAT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)